» Articles » PMID: 26939331

[Effects of Acupuncture-moxibustion on Contents of IL-12 and TNF-α in Spleen of Cyclophosphamide- Induced Cancer-bearing Mice]

Overview
Date 2016 Mar 5
PMID 26939331
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore the molecular biology mechanism of acupuncture on improving immune function damage induced by chemotherapy in cancer-bearing mice.

Methods: Seventy-two mice (36 mice in 3-day treatment and 5-day treatment, respectively) which were successfully made into cancer-bearing model were divided into a blank group, a model group, an acupuncture group and a moxibustion group by stratified randomization method, 9 mice in each one. Except for the mice in the blank group, the remaining mice were treated with intra-peritoneal injection of cyclophosphamide (CTX, 150 mg/kg), to establish the cancer-bearing mice of CTX. The mice in the blank group were treated with intraperitoneal injection of 0.9% NaCl (identical dose as other groups). After 4 h, the mice in the acupuncture group and moxibustion group were treated with acupuncture and moxibustion at "Dazhui" (GV 14), "Geshu" (BL 17), "Shenshu" (BL 23), "Zusanli" (ST 36), once a day. The mice in the blank group and model group were treated with immobilization and fixation during the same time. On the next day of the end of 3-day and 5-day treatment, the sample was collected. The ELISA method was applied to measure the contents of IL-12 and TNF-α in spleen of all the mice.

Results: After 3-day and 5-day treatment, compared with the blank group, the contents of IL-12 and TNF-α in spleen in the model group were reduced (all P < 0.05); compared with the model group, the contents of IL-12 and TNF-α in spleen in the acupuncture group and moxibustion group were increased (all P < 0.05), but the content of IL-12 and TNF-α in the acupuncture group was not different from that in the moxibustion group (both P > 0.05).

Conclusion: Acupuncture and moxibustion could effectively increase the contents of IL-12 and TNF-α in spleen of CTX cancer-bearing mice, which could relieve chemotherapy-induced immune function damage to improve immune function.

Citing Articles

Moxibustion for the Treatment of Cancer and its Complications: Efficacies and Mechanisms.

Lu S, Wang B, Wang J, Guo Y, Li S, Zhao S Integr Cancer Ther. 2023; 22:15347354231198089.

PMID: 37746720 PMC: 10521285. DOI: 10.1177/15347354231198089.


Efficacy of press needle on immune function and quality of life in female breast cancer patients after radical mastectomy: study protocol for a randomized controlled trial.

Ying G, Yao W, Hongchun C, Ran Y, Tao L, Jinhao Z J Tradit Chin Med. 2023; 43(2):374-378.

PMID: 36994527 PMC: 10012207. DOI: 10.19852/j.cnki.jtcm.20221226.002.


Effect of moxibustion on quality of life after chemotherapy in patients with the malignant tumor: A protocol for systematic review and meta analysis.

Tao D, Xu J, Zou S, Tan Y, Ai S Medicine (Baltimore). 2021; 100(3):e23471.

PMID: 33545928 PMC: 7837930. DOI: 10.1097/MD.0000000000023471.


Moxibustion Alleviates Injury in a Rat Focal Segmental Glomerulosclerosis Model.

Li Y, Sun Y, Zhang C, Wang K, Shen P, Huang D Evid Based Complement Alternat Med. 2017; 2017:7169547.

PMID: 28630634 PMC: 5467354. DOI: 10.1155/2017/7169547.